October 31, 2019 8:27am

US futures point to a negative open after conflicting reports of China trade deal as Fed signals a pause in rate cuts

Earnings season remains high on the agenda for investors: Intellia Therapeutics (NTLA) and Alnylam Pharmaceuticals (ALNY)

When you’re on a roller coaster, the only thing you can be sure of is you’ll end up back where you started …


My version of the morning’s numbers is written to be informative than just about changes to fundamentals; it’s what happened or will beyond the headline and what could happen to the future


Dow futures are DOWN -0.26% (-71 points), S&P futures are DOWN -0.28% (-9 points) and NASDAQ futures are DOWN -0.17% (-14 points)


U.S. stock index futures are lower on Thursday morning;

European stocks reversed early gains to trade lower with the pan-European Stoxx 600 dropping - 0.6%;

Asia Pacifics stocks were mixed as China's manufacturing activity shrunk;


Data Docket: PCE (personal consumption expenditure) price index and Core PCE price index figures, along with personal income and spending.



Early Thursday, Bloomberg News reported, citing unnamed sources, that Chinese officials have been casting doubt over the possibility of a long-term trade deal with the U.S., despite the two sides closing in on an initial “phase one” accord, sending stock futures tumbling <CNBC>.

U.K. Prime Minister Boris Johnson and main opposition leader Jeremy Corbyn begin their first full day of campaigning ahead of what promises to be a historic December election.


It’s all about what happened yesterday to stir the up or downside for today! Or. the only good day was yesterday and that s...ed!


Wednesday night’s newsletter heading: “strength came from trading the downside; low volume is still the standard.”

  • The NASDAQ closed UP +27.12 points (+0.33%)
  • The IBB closed up +0.13% while the XBI closed down -0.42%
  • The close was negative with an A/D line of 13/27, 2 flats, 1 reversed merged (HSGX) and 2 acquired;
  • The range of the 13 upside was +0.39% (GBT) to +38.69% (CUR) while the 27 downside ranged from -0.17% (ONVO) to -13.60% (VSTM);
  • 5 out of the 13 upside had higher than the 3 month average volume;
  • 5 out of the 27 downside had higher than the 3 month average volume;


  • October registered 10 positive, 1 neutral and 13 negative close, so far …
  • September, there were 1 holiday, 11 negative, 7 positive and 2 non reported sessions;


Companies in my headlights – It’s your decision; I provide an idea and context:

*** I haven’t changed …  follow the trading herd but … mindful of upcoming quarterly results  and their effect upon share pricing … BUY and get trampled in the coming sessions or SELL into strength or just HOLD and wait to resolve relieve the anxiety until value returns.



Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.